Correction to “Patent Review of Manufacturing Routes to Recently Approved Oncology Drugs: Ibrutinib, Cobimetinib, and Alectinib”David L. Hughespp 138–140Publication Date (Web): December 30, 2016 (Addition/Correction)DOI: 10.1021/acs.oprd.6b00423Original Article